BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 25633867)

  • 1. Cleaved NOTCH1 Expression Pattern in Head and Neck Squamous Cell Carcinoma Is Associated with NOTCH1 Mutation, HPV Status, and High-Risk Features.
    Rettig EM; Chung CH; Bishop JA; Howard JD; Sharma R; Li RJ; Douville C; Karchin R; Izumchenko E; Sidransky D; Koch W; Califano J; Agrawal N; Fakhry C
    Cancer Prev Res (Phila); 2015 Apr; 8(4):287-95. PubMed ID: 25633867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HEY1 is expressed independent of NOTCH1 and is associated with poor prognosis in head and neck squamous cell carcinoma.
    Rettig EM; Bishop JA; Agrawal N; Chung CH; Sharma R; Zamuner F; Li RJ; Koch WM; Califano JA; Guo T; Gaykalova DA; Fakhry C
    Oral Oncol; 2018 Jul; 82():168-175. PubMed ID: 29909892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
    Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
    Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV.
    Walline HM; Carey TE; Goudsmit CM; Bellile EL; D'Souza G; Peterson LA; McHugh JB; Pai SI; Lee JJ; Shin DM; Ferris RL;
    Mol Cancer Res; 2017 Feb; 15(2):179-188. PubMed ID: 27899422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma.
    Sajed DP; Faquin WC; Carey C; Severson EA; H Afrogheh A; A Johnson C; Blacklow SC; Chau NG; Lin DT; Krane JF; Jo VY; Garcia JJ; Sholl LM; Aster JC
    Am J Surg Pathol; 2017 Nov; 41(11):1473-1482. PubMed ID: 28914715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
    Westra WH; Taube JM; Poeta ML; Begum S; Sidransky D; Koch WM
    Clin Cancer Res; 2008 Jan; 14(2):366-9. PubMed ID: 18223210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.
    Báez A; Cantor A; Fonseca S; Marcos-Martinez M; Mathews LA; Muro-Cacho CA; Muñoz-Antonia T
    Clin Cancer Res; 2005 May; 11(9):3191-7. PubMed ID: 15867212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma.
    Liu J; Zhang M; Rose B; Veillard AS; Jones D; Zhang X; Soon Lee C; Milross C; Hong A
    Ann Surg Oncol; 2015; 22(6):1893-900. PubMed ID: 25404475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the antileukoprotease SLPI in smoking-induced human papillomavirus-independent head and neck squamous cell carcinomas.
    Quabius ES; Möller P; Haag J; Pfannenschmidt S; Hedderich J; Görögh T; Röcken C; Hoffmann M
    Int J Cancer; 2014 Mar; 134(6):1323-34. PubMed ID: 23996702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [p53 mutations and HPV infections in squamous epithelial carcinomas of the head-neck region. Long-term follow-up].
    Riethdorf S; Friedrich RE; Sühwold J; Ostwald C; Barten M; Gogacz P; Gundlach KK; Schlechte H; Becker J; Bregenzer T; Riethdorf L; Löning T
    Mund Kiefer Gesichtschir; 1998 Jan; 2(1):30-4. PubMed ID: 9522570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NOTCH Pathway in Head and Neck Squamous Cell Carcinoma.
    Fukusumi T; Califano JA
    J Dent Res; 2018 Jun; 97(6):645-653. PubMed ID: 29489439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population.
    Maruyama H; Yasui T; Ishikawa-Fujiwara T; Morii E; Yamamoto Y; Yoshii T; Takenaka Y; Nakahara S; Todo T; Hongyo T; Inohara H
    Cancer Sci; 2014 Apr; 105(4):409-17. PubMed ID: 24521534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NRF2, p53, and p16: Predictive biomarkers to stratify human papillomavirus associated head and neck cancer patients for de-escalation of cancer therapy.
    Ramesh PS; Devegowda D; Singh A; Thimmulappa RK
    Crit Rev Oncol Hematol; 2020 Apr; 148():102885. PubMed ID: 32062315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours.
    Ragin CC; Taioli E; Weissfeld JL; White JS; Rossie KM; Modugno F; Gollin SM
    Br J Cancer; 2006 Nov; 95(10):1432-8. PubMed ID: 17003776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of TP53 mutations, codon 72 polymorphism and human papillomavirus in head and neck squamous cell carcinoma patients.
    Shi Q; Xiao K; Wei W; Zhang BY; Chen C; Xu Y; Chen LN; Song YT; Ma X; Zhang NS; Dong XP
    Oncol Rep; 2013 Dec; 30(6):2811-9. PubMed ID: 24064928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.
    Riva G; Pecorari G; Biolatti M; Pautasso S; Lo Cigno I; Garzaro M; Dell'Oste V; Landolfo S
    Mol Biol Rep; 2019 Jun; 46(3):3333-3347. PubMed ID: 30980272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of EGFR, VEGF, and NOTCH1 suggest differences in tumor angiogenesis in HPV-positive and HPV-negative head and neck squamous cell carcinoma.
    Troy JD; Weissfeld JL; Youk AO; Thomas S; Wang L; Grandis JR
    Head Neck Pathol; 2013 Dec; 7(4):344-55. PubMed ID: 23645351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
    Seiwert TY; Zuo Z; Keck MK; Khattri A; Pedamallu CS; Stricker T; Brown C; Pugh TJ; Stojanov P; Cho J; Lawrence MS; Getz G; Brägelmann J; DeBoer R; Weichselbaum RR; Langerman A; Portugal L; Blair E; Stenson K; Lingen MW; Cohen EE; Vokes EE; White KP; Hammerman PS
    Clin Cancer Res; 2015 Feb; 21(3):632-41. PubMed ID: 25056374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8.
    Hafkamp HC; Speel EJ; Haesevoets A; Bot FJ; Dinjens WN; Ramaekers FC; Hopman AH; Manni JJ
    Int J Cancer; 2003 Nov; 107(3):394-400. PubMed ID: 14506739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.